Sovaldi price gouging - Graphic: This Is How Sovaldi Price-Gouging Is Costing
Philadelphia’s transit agency has sued Gilead Sciences, accusing the company of “price-gouging” on the sale of its $1,000-per-pill hepatitis C drug Sovaldi, the
Drugs that are almost 100 percent effective in curing Hepatitis C are so expensive, many patients are unable to get them.
Are consumers getting gouged on health care? Sovaldi is the first That price has prompted accusations of price-gouging from the insurance industry.
The Economist-Kerrisdale Capital Case Study Competition 2015 unsustainable business model of price gouging and providing non Sovaldi and Harvoni, Gilead’s
Price Gouging. Price gouging is illegal, and the Office of the Attorney General has authority to prosecute any business that engages in price gouging after a disaster
2/21/2014A federal lawsuit alleging price gouging by the maker of hepatitis C drug Sovaldi mirrors a growing struggle to contain hepatitis C-related workers